InoCardia

United Kingdom
Coventry, England, United Kingdom
+44 (0)7988 563489 ★

Company profile

InoCardia company profile

Inocardia is a Coventry University spinout focused on the provision of Contract Research Services via the development of assays targeted at the biotech and pharmaceutical sectors. Inocardia has developed the ‘work-loop’ model as a pre-clinical myocardial assay assessing cardiac contractility in normal, diseased and ageing myocardium in order to determine the cardiovascular safety of lead pharmaceutical compounds. The Coventry University work-loop assay is the only relevant in-vitro human model of cardio-toxicity available worldwide. Both the pharmaceutical industry and regulators recognise that contractility assessment is currently fraught with problems.

Business identity

Contact email
[email protected]
Phone number
+44 (0)7988 563489
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2013-01-01

Headquarters

Headquarters
Coventry, England, United Kingdom
Postal code
CV1 2TT
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$391K
Last funding
Series Unknown / $391K / 2014-07-21
Last equity funding
Series Unknown / $391K
Investors
1
Lead investors
1
Founders
1
Articles
2

Founders and investors

Founders

Helen Maddock

Lead investors

Mercia Fund Managers

Investors

Mercia Fund Managers

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.